Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 157

1.

Optimising Aortic Endovascular Repair in Patients with Marfan Syndrome.

Pellenc Q, Girault A, Roussel A, De Blic R, Cerceau P, Raffoul R, Milleron O, Jondeau G, Castier Y.

Eur J Vasc Endovasc Surg. 2019 Dec 18. pii: S1078-5884(19)32014-3. doi: 10.1016/j.ejvs.2019.09.501. [Epub ahead of print]

PMID:
31865029
2.

European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants.

van de Laar IMBH, Arbustini E, Loeys B, Björck E, Murphy L, Groenink M, Kempers M, Timmermans J, Roos-Hesselink J, Benke K, Pepe G, Mulder B, Szabolcs Z, Teixidó-Turà G, Robert L, Emmanuel Y, Evangelista A, Pini A, von Kodolitsch Y, Jondeau G, De Backer J.

Orphanet J Rare Dis. 2019 Nov 21;14(1):264. doi: 10.1186/s13023-019-1186-2.

3.

Incidence of cardiovascular events and risk markers in a prospective study of children diagnosed with Marfan syndrome.

Hascoet S, Edouard T, Plaisancie J, Arnoult F, Milleron O, Stheneur C, Chevallier B, Zordan C, Odent S, Bal L, Faivre L, Leheup B, Dupuis-Girod S, Ruidavets JB, Acar P, Ferrieres J, Jondeau G, Dulac Y.

Arch Cardiovasc Dis. 2019 Nov 14. pii: S1875-2136(19)30191-3. doi: 10.1016/j.acvd.2019.09.010. [Epub ahead of print]

PMID:
31735609
4.

Effects of Serelaxin in Patients with Acute Heart Failure.

Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stępińska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C; RELAX-AHF-2 Committees Investigators.

N Engl J Med. 2019 Aug 22;381(8):716-726. doi: 10.1056/NEJMoa1801291.

PMID:
31433919
5.

Genetic testing for aortopathies: primer for the nongeneticist.

De Backer J, Jondeau G, Boileau C.

Curr Opin Cardiol. 2019 Nov;34(6):585-593. doi: 10.1097/HCO.0000000000000669.

PMID:
31397689
6.

Genetic counselling and testing in adults with congenital heart disease: A consensus document of the ESC Working Group of Grown-Up Congenital Heart Disease, the ESC Working Group on Aorta and Peripheral Vascular Disease and the European Society of Human Genetics.

De Backer J, Bondue A, Budts W, Evangelista A, Gallego P, Jondeau G, Loeys B, Peña ML, Teixido-Tura G, van de Laar I, Verstraeten A, Roos Hesselink J.

Eur J Prev Cardiol. 2019 Jun 11:2047487319854552. doi: 10.1177/2047487319854552. [Epub ahead of print]

PMID:
31184212
7.

Systems pharmacology-based integration of human and mouse data for drug repurposing to treat thoracic aneurysms.

Hansen J, Galatioto J, Caescu CI, Arnaud P, Calizo RC, Spronck B, Murtada SI, Borkar R, Weinberg A, Azeloglu EU, Bintanel-Morcillo M, Gallo JM, Humphrey JD, Jondeau G, Boileau C, Ramirez F, Iyengar R.

JCI Insight. 2019 Jun 6;4(11). pii: 127652. doi: 10.1172/jci.insight.127652. eCollection 2019 Jun 6.

8.

Pulmonary hemodynamic effects of interatrial shunt in heart failure with preserved ejection fraction in rats.

Danial P, Dupont S, Escoubet B, Osborne-Pellegrin M, Jondeau G, Michel JB.

EuroIntervention. 2019 May 7. pii: EIJ-D-18-01100. doi: 10.4244/EIJ-D-18-01100. [Epub ahead of print]

9.

Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC).

Roos-Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, Jondeau G, Budts W, Grewal J, Sliwa K, Parsonage W, Maggioni AP, van Hagen I, Vahanian A, Tavazzi L, Elkayam U, Boersma E, Hall R.

Eur Heart J. 2019 Dec 14;40(47):3848-3855. doi: 10.1093/eurheartj/ehz136.

PMID:
30907409
10.

False lumen embolization in chronic aortic dissection promotes thoracic aortic remodeling at midterm follow-up.

Pellenc Q, Roussel A, De Blic R, Girault A, Cerceau P, Ben Abdallah I, Milleron O, Jondeau G, Castier Y.

J Vasc Surg. 2019 Sep;70(3):710-717. doi: 10.1016/j.jvs.2018.11.038. Epub 2019 Mar 6.

PMID:
30850289
11.

Clinical Significance of Aortic Root Modification Associated With Bicuspid Aortic Valve in Marfan Syndrome.

Milleron O, Ropers J, Arnoult F, Bouleti C, Delorme G, Langeois M, Tchitchinadze M, Guien C, Beroud C, Boileau C, Jondeau G.

Circ Cardiovasc Imaging. 2019 Mar;12(3):e008129. doi: 10.1161/CIRCIMAGING.118.008129.

PMID:
30841707
12.

Reference Expression Profile of Three FBN1 Transcript Isoforms and Their Association with Clinical Variability in Marfan Syndrome.

Benarroch L, Aubart M, Gross MS, Arnaud P, Hanna N, Jondeau G, Boileau C.

Genes (Basel). 2019 Feb 11;10(2). pii: E128. doi: 10.3390/genes10020128.

13.

Genetic diversity and pathogenic variants as possible predictors of severity in a French sample of nonsyndromic heritable thoracic aortic aneurysms and dissections (nshTAAD).

Arnaud P, Hanna N, Benarroch L, Aubart M, Bal L, Bouvagnet P, Busa T, Dulac Y, Dupuis-Girod S, Edouard T, Faivre L, Gouya L, Lacombe D, Langeois M, Leheup B, Milleron O, Naudion S, Odent S, Tchitchinadze M, Ropers J, Jondeau G, Boileau C.

Genet Med. 2019 Sep;21(9):2015-2024. doi: 10.1038/s41436-019-0444-y. Epub 2019 Feb 11.

PMID:
30739908
14.

SMAD3 pathogenic variants: risk for thoracic aortic disease and associated complications from the Montalcino Aortic Consortium.

Hostetler EM, Regalado ES, Guo DC, Hanna N, Arnaud P, Muiño-Mosquera L, Callewaert BL, Lee K, Leal SM, Wallace SE, Rideout AL, Dyack S, Aatre RD, Boileau C, De Backer J, Jondeau G, Milewicz DM.

J Med Genet. 2019 Apr;56(4):252-260. doi: 10.1136/jmedgenet-2018-105583. Epub 2019 Jan 19.

PMID:
30661052
15.

AVIATOR: An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm.

de Heer F, Kluin J, Elkhoury G, Jondeau G, Enriquez-Sarano M, Schäfers HJ, Takkenberg JJM, Lansac E; Aortic Valve Repair Research Network Investigators.

J Thorac Cardiovasc Surg. 2019 Jun;157(6):2202-2211.e7. doi: 10.1016/j.jtcvs.2018.10.076. Epub 2018 Oct 26.

PMID:
30553597
16.

Risk of Ascending Aortic Aneurysm in Patients With Autosomal Dominant Polycystic Kidney Disease.

Bouleti C, Flamant M, Escoubet B, Arnoult F, Milleron O, Vidal-Petiot E, Langeois M, Ou P, Vrtovsnik F, Jondeau G.

Am J Cardiol. 2019 Feb 1;123(3):482-488. doi: 10.1016/j.amjcard.2018.10.030. Epub 2018 Nov 6.

PMID:
30477801
17.

Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity.

Richard P, Ader F, Roux M, Donal E, Eicher JC, Aoutil N, Huttin O, Selton-Suty C, Coisne D, Jondeau G, Damy T, Mansencal N, Casalta AC, Michel N, Haentjens J, Faivre L, Lavoute C, Nguyen K, Tregouët DA, Habib G, Charron P.

Clin Genet. 2019 Mar;95(3):356-367. doi: 10.1111/cge.13484. Epub 2018 Dec 27.

18.

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.

Kaye DM, Petrie MC, McKenzie S, Hasenfuβ G, Malek F, Post M, Doughty RN, Trochu JN, Gustafsson F, Lang I, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Hausleiter J, Raake P, Jondeau G, Bergmann MW, Spelman T, Aytug H, Ponikowski P, Hayward C; REDUCE LAP-HF study investigators.

ESC Heart Fail. 2019 Feb;6(1):62-69. doi: 10.1002/ehf2.12350. Epub 2018 Oct 11.

19.

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. No abstract available.

PMID:
30165544
20.

Marfan Syndrome Variability: Investigation of the Roles of Sarcolipin and Calcium as Potential Transregulator of FBN1 Expression.

Benarroch L, Aubart M, Gross MS, Jacob MP, Arnaud P, Hanna N, Jondeau G, Boileau C.

Genes (Basel). 2018 Aug 21;9(9). pii: E421. doi: 10.3390/genes9090421.

Supplemental Content

Loading ...
Support Center